Author(s)

Tamás Erdélyi¹, Anikó Bohács¹, Krisztina Vincze¹, Zsuzsanna Kováts¹, Veronika Sárosi², András Sinkovicz², György Balázs³, Veronika Müller¹

¹Department of Pulmonology, Semmelweis University, Budapest, Hungary.
²1st Department of Internal Medicine, Medical School, University of Pécs, Pécs, Hungary.
³Department of Radiology, The Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Lymphangioleiomyomatosis (LAM) is a rare disease that affects women, especially in child-bearing age. Clinical manifestations include angiomyolipoma, pneumothorax, chylothorax, cystic changes of lungs and progressive pulmonary failure. In this article, we report a case of lung transplantation (LuTX) for end stage pulmonary LAM and the treatment of angiomyolipoma showing growth after LuTX resulting in complete remission with combination therapy of everolimus and tacrolimus.

Lymphangioleiomyomatosis, Everolimus, Angiomyolipoma, Lung Transplant

Erdélyi, T. , Bohács, A. , Vincze, K. , Kováts, Z. , Sárosi, V. , Sinkovicz, A. , Balázs, G. and Müller, V. (2014) Successful Tacrolimus Therapy Extended by Everolimus in Retroperitoneal Angiomyolipoma after Lung Transplantation: A Case Report. Case Reports in Clinical Medicine, 3, 636-638. doi: 10.4236/crcm.2014.312135.